Prenylation of CaaX-type proteins: Basic principles through clinical applications

Current Topics in Membranes

Volumn 52, Issue , 2002, Pages 531-550

  Hurwitz, Herbert I ^a   Casey, Patrick J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646014197     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s1063-5823(02)52021-4     Document Type: Review

References (94)

1. P. Adamson C.J. Marshall A. Hall P.A. Tilbrook Post-translational modifications of p21 rho proteins J. Biol. Chem. 267 1992 20033 20038
2. A.A. Adjei C. Erlichman J.N. Davis D.L. Cutler J.A. Sloan R.S. Marks L.J. Hanson P.A. Svingen P. Atherton W.R. Bishop A phase I trial of the famesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity Cancer Res. 60 2000 1871 1877
3. S.A. Armstrong V.C. Hannah J.L. Goldstein M.S. Brown CaaX geranylgeranyl transferase transfers famesyl as efficiently as geranylgeranyl to RhoB J. Biol. Chem. 270 1995 7864 7868
4. H.R. Ashar L. James K. Gray D. Carr S. Black L. Armstrong W.R. Bishop P. Kirschmeier Farnesyl transferase inhibitors block the famesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules J. Biol. Chem. 275 2000 30451 30457
5. M.N. Ashby CaaX converting enzymes Curr. Opin. Lipidol. 9 1998 99 102
6. M. Barbacid Ras genes Annu. Rev. Biochem. 56 1987 779 827
7. M.O. Bergo G.K. Leung P. Ambroziak J.C. Otto P.J. Casey S.G. Young Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells J. Biol. Chem. 275 2000 17605 17610
8. W.R. Bishop R. Bond J. Petrin L. Wang R. Patton R. Doll G. Njoroge J. Catino J. Schwartz W. Windsor Novel tricyclic inhibitors of farnesyl protein transferase J. Biol. Chem. 270 1995 30611 30618
9. W.R.K. Bishop J.J. Pai L. Armstrong M. Dalton R.J. Doll A. Taveras G. Njoroge M. Sinensky F. Zhang M. Liu P. Kirschmeier Tricyclic farnesyl protein transferase inhibitors S.M. Sebti A.D. Hamilton Farnesyltransferase Inhibitors in Cancer Therapy 2001 Humana Press Tampa, FL 87 101
10. M.S. Boguski F. McCormick Proteins regulating Ras and its relatives Nature 366 1993 643 654
11. J.L. Bos Ras oncogenes in human cancer: A review Cancer Res. 49 1989 4682 4689
12. J.M. Carboni N. Yan A.D. Cox X. Bustelo S.M. Graham M.J. Lynch R. Weinmann B.R. Seizinger C.J. Der M. Barbacid V. Manne Farnesyltransferase inhibitors are inhibitors of Ras, but not R-Ras2/TC21, transformation Oncogene 10 1995 1905 1913
13. P.J. Casey M.C. Seabra Protein prenyltransferases J. Biol. Chem. 271 1996 5289 5292
14. P.J. Casey J.A. Thissen J.F. Moomaw Enzymatic modification of proteins with a geranylgeranyl isoprenoid Proc. Natl. Acad. Sci. USA 88 1991 8631 8635
15. W.-J. Chen J.F. Moomaw L. Overton T.A. Kost P.J. Casey High-level expression of mammalian protein farnesyltransferase in a baculovirus system: The purified protein contains zinc J. Biol. Chem. 268 1993 9675 9680
16. G.J. Clark M.S. Kinch K. Rogers-Graham S.M. Sebti A.D. Hamilton C.J. Der The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation J. Biol. Chem. 272 1997 10608 10615
17. S. Clarke Protein isoprenylation and methylation at carboxyl-terminal cysteine residues Annu. Rev. Biochem. 61 1992 355 386
18. A.D. Cox C.J. Der Farnesyltransferase inhibitors and cancer treatment: Targeting simply Ras? Biochim. Biophys. Acta 1333 1997 F51 F71
19. M. Crul G.J. de Klerk J.H. Beijnen J.H. Schellens Ras biochemistry and farnesyl transferase inhibitors: A literature survey Anticancer Drugs 12 2001 163 184
20. J.M. Dolence C.D. Poulter A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase Proc. Natl. Acad. Sci. USA 92 1995 5008 5011
21. H.W. Fu P.J. Casey Enzymology and biology of CaaX protein prenylation Rec. Prog. Hormone Res. 54 1999 315 343
22. E.S. Furfine J.J. Leban A. Landavazo J.F. Moomaw P.J. Casey Protein farnesyltransferase: Kinetics of farnesyl pyrophosphate binding and product release Biochemistry 34 1995 6857 6862
23. J.C. Gebler A.B. Woodside C.D. Poulter Dimethylallytryptophan synthase: An enzymecatalyzed electrophilic aromatic substitution J. Am. Chem. Soc. 114 1992 7354 7360
24. M.H. Gelb Protein prenylation: Signal transduction in two dimensions Science 275 1997 1750 1751
25. J.B. Gibbs Ras C-terminal processing enzymes: New drug targets? Cell 65 1991 1 4
26. J.B. Gibbs A. Oliff The potential of farnesyltransferase inhibitors as cancer chemotherapeutics Annu. Rev. Pharmacol. Toxicol. 37 1997 143 166
27. J.B. Gibbs D.L. Pompliano S.D. Mosser E. Rands R.B. Lingham S.B. Singh E.M. Scolnick N.E. Kohl A. Oliff Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo J. Biol. Chem. 268 1993 7617 7620
28. J.B. Gibbs S.L. Graham G.D. Hartman K.S. Koblan N.E. Kohl C.A. Omer A. Oliff Farnesyltransferase inhibitors versus Ras inhibitors Curr. Opin. Chem. Biol. 1 1997 197 203
29. J.A. Glomset M.H. Gelb C.C. Farnsworth Prenyl proteins in eukaryotic cells: A new type of membrane anchor Trends Biochem. Sci. 15 1990 139 142
30. J.L. Goldstein M.S. Brown S.J. Stradley Y. Reiss L.M. Gierasch Nonfarnesylated tetrapeptide inhibitors of protein famesyltransferase J. Biol. Chem. 266 1991 15575 15578
31. S.L. Graham T.M. Williams Inhibitors of protein farnesylation Exp. Opin. Therapeutic Patents 6 1996 1295 1304
32. J.F. Hancock A.I. Magee J.E. Childs C.J. Marshall All Ras proteins are polyisoprenylated but only some are palmitoylated Cell 57 1989 1167 1177
33. K.E. Hightower C.A. Fierke Zinc-catalyzed sulfur alkylation: Insights from protein farnesyltransferase Curr. Opin. Chem. Biol. 3 1998 176 181
34. K.E. Hightower C.-C. Huang P.J. Casey C.A. Fierke H-Ras peptide and protein substrates bind protein farnesyltransferase as an ionized thiolate Biochemistry 37 1998 15555 15562
35. 2+-FTase indicates metal coordination of the substrate thiolate J. Biol. Chem. 272 1997 20 23
36. C.-C. Huang K.E. Hightower C.A. Fierke Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state Biochemistry 39 2000 2593 2602
37. G.R. Hudes J. Schol Phase I trial of oral R115777 in patients with refractory solid tumors S.M. Sebti A.D. Hamilton Faresyltransferase Inhibitors in Cancer Therapy 2001 Humana Press Tampa, FL 251 254
38. J.H. Jackson C.G. Cochrane J.R. Boume P.A. Solski J.E. Buss C.J. Der Farnesol modification of Kirsten-Ras exon 4B protein is essential for transformation Proc. Natl. Acad. Sci. USA 87 1990 3042 3046
39. G.L. James J.L. Goldstein M.S. Brown T.E. Rawson T.C. Somers R.S. McDowell C.W. Crowley B.K. Lucas A.D. Levinson J.C. Marsters Jr Benzodiazepine peptidomimetics: Potent inhibitors of Ras farnesylation in animal cells Science 260 1993 1937 1942
40. G.L. James J.L. Goldstein M.S. Brown Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro J. Biol. Chem. 270 1995 6221 6226
41. G. James J.L. Goldstein M.S. Brown Resistance of K-RasBv12 proteins to farnesyltransferase inhibitors in Ratl cells Proc. Natl. Acad. Sci. USA 93 1996 4454 4458
42. S.R. Johnston Farnesyl transferase inhibitors: A novel targeted therapy for cancer Lancet Oncol. 2 2001 18 26
43. M.K. Jones J.H. Jackson Ras-GRF activates Ha-Ras, but not N-Ras or K-Ras 413, protein in vivo J. Biol. Chem. 273 1998 1782 1787
44. E. Kim P. Ambroziak J.C. Otto B. Taylor M. Ashby K. Shannon P.J. Casey S.G. Young Disruption of the mouse Rce 1 gene results in defective ras processing and mislocalization of ras within cells J. Biol. Chem. 274 1999 8383 8390
45. K. Koera K. Nakamura K. Nakao J. Miyoshi K. Toyoshima T. Hatta H. Otani A. Aiba M. Katsuki K-Ras is essential for the development of the mouse embryo Oncogene 15 1997 1151 1159
46. N.E. Kohl R.E. Diehl M.D. Schaber E. Rands D.D. Soderman B. He S.L. Moores D.L. Pompliano S. Ferro-Novick S. Powers Structural homology among mammalian and Saccharomyces cerevisiae isoprenyl-protein transferases J. Biol. Chem. 266 1991 18884 18888
47. N.E. Kohl S.D. Mosser S.J. Dessolms E.A. Giuliani D.L. Pompliano S.L. Graham R.L. Smith E.M. Scolnick A. Oliff J.B. Gibbs Selective inhibition of Ras-dependent transformation by a famesyltransferase inhibitor Science 260 1993 1934 1937
48. P.F. Lebowitz J.P. Davide G.C. Prendergast Evidence that famesyltransferase inhibitors suppress ras transformation by interfering with Rho activity Mol. Cell. Biol. 15 1995 6613 6622
49. P.F. Lebowitz P.J. Casey G.C. Prendergast J.A. Thissen Faresyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB J. Biol. Chem. 272 1997 15591 15594
50. P.E. Lebowitz D. Sakamuro G.C. Prendergast Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment Cancer Res. 57 1997 708 713
51. G.M. LeClerc D.A. Grahame Methylcobamide:coenzyme M methyltransferase isozymes from Methanosarcina barkeri J. Biol. Chem. 271 1996 18725 18731
52. S.B. Long P.J. Casey L.S. Beese Co-crystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate Biochemistry 37 1998 9612 9618
53. S.B. Long P.J. Casey L.S. Beese The basis for K-Ras4B binding specificity to protein famesyltransferase revealed by 2 A resolution ternary complex structures Structure 8 1999 209 222
54. V. Manne F. Lee N. Yan C. Fairchild W.C. Rose Development of famesyltransferase inhibitors as potential intitumor agents S.M. Sebti A.D. Hamilton Faresyltransferase Inhibitors in Cancer Therapy 2001 Humana Press Tampa, FL 71 86
55. C.J. Marshall Protein prenylation: A mediator of protein-protein interactions Science 259 1993 1865 1866
56. R.G. Matthews C.W. Goulding Enzyme-catalyzed methyl transfers to thiols: The role of zinc Curr. Opin. Chem. Biol. 1 1998 332 339
57. J.F. Moomaw P.J. Casey Mammalian protein geranylgeranyltransferase: Subunit composition and metal requirements J. Biol. Chem. 267 1992 17438 17443
58. L.C. Myers M.P. Terranova A.E. Ferentz G. Wagner G.L. Verdine Repair of DNA methylphosphotriesters through a metalloactivated cysteine nucleophile Science 261 1993 1164 1167
59. T. Nagasu K. Yoshimatsu C. Rowell M.D. Lewis A.M. Garcia Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956 Cancer Res. 55 1995 5310 5314
60. H.-W. Park L.S.B. Beese Protein farnesyltransferase Curr. Opin. Struct. Biol. 7 1997 873 880
61. H.-W. Park S.R. Boduluri J.F. Moomaw P.J. Casey L.S. Beese Crystal structure of protein farnesyltransferase at 2.25 Å resolution Science 275 1997 1800 1804
62. D.V. Patel R.J. Schmidt S.A. Biller E.M. Gordon S.S. Robinson V. Manne Farnesyl diphosphate-based inhibitors of Ras farnesyl protein transferase J. Med. Chem. 38 1995 2906 2921
63. P. Pellicena J.D. Scholten K. Zimmerman M. Creswell C.C. Huang W.T. Miller Involvement of the alpha subunit of farnesyl-protein transferase in substrate recognition Biochemistry 35 1996 13494 13500
64. D.L. Pompliano E. Rands M.D. Schaber S.D. Mosser N.J. Anthony J.B. Gibbs Steady-state kinetic mechanism of ras farnesyl:protein transferase Biochemistry 31 1992 3800 3807
65. C.D. Poulter P.L. Wiggins A.T. Le Farnesylpyrophosphate synthetase: A new stepwise mechanism for the 1′-4 condensation reaction J. Am. Chem. Soc. 103 1981 3926 3927
66. C.D. Poulter T.L. Capson T.D. Thompson R.S. Bard Squalene synthetase: Inhibition by ammonium analogues of carbocationic intermediates in the conversion of presqualene diphosphate to squalene J. Am. Chem. Soc. 111 1989 3734 3739
67. G.C. Prendergast Effects of famesyltransferase inhibitors on cytoskeleton, cell transformation, and tumorigenesis S.M. Sebti A.D. Hamilton Farnesyltransferase Inhibitors in Cancer Therapy 2001 Humana Press Tampa, FL 159 169
68. G.C. Prendergast A. Oliff Farnesyltransferase inhibitors: Antineoplastic properties, mechanisms of action, and clinical prospects Semin. Cancer Biol. 10 2000 443 452
69. Y. Reiss J.L. Goldstein M.C. Seabra P.J. Casey M.S. Brown Inhibition of purified p2lras famesyl:protein transferase by Cys-aaX tetrapeptides Cell 62 1990 81 88
70. Y. Reiss M.C. Seabra S.A. Armstrong C.A. Slaughter J.L. Goldstein M.S. Brown Nonidentical subunits of p21 H-Ras famesyltransferase: Peptide binding and farnesyl pyrophosphate carrier functions J. Biol. Chem. 266 1991 10672 10677
71. Y. Reiss M.S. Brown J.L. Goldstein Divalent cation and prenyl pyrophosphate specificities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme J. Biol. Chem. 267 1992 6403 6408
72. C.A. Rowell J.J. Kowalczyk M.D. Lewis A.M. Garcia Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo J. Biol. Chem. 272 1997 14093 14097
73. W.R. Schafer J. Rine Protein prenylation: Genes, enzymes, targets and functions Annu. Rev. Genet. 25 1992 209 238
74. W.R. Schafer R. Kim R. Sterne J. Thomer S.-H. Kim J. Rine Genetic and pharmacological suppression of oncogenic mutations in Ras genes of yeast and humans Science 245 1989 379 385
75. M.C. Seabra Y. Reiss P.J. Casey M.S. Brown J.L. Goldstein Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit Cell 65 1991 429 434
76. J.S. Sebolt-Leopold D.M. Deonard W.R. Leopold Histidylbenzylglycinamides: A novel class of farnesyl diphosphate-competitive peptidic farnesyltransferase inhibitors S.M. Sebti A.D. Hamilton Farnesyltransferase Inhibitors in Cancer Therapy 2001 Humana Press Tampa, FL 103 114
77. S.M. Sebti A.D. Hamilton Inhibition of ras prenylation: A novel approach to cancer chemotherapy Pharmacol. Therapeutics 74 1997 103 114
78. S.M. Sebti A.D. Hamilton Farnesyltransferase and geranylgeranyltransferase I inhibitors as novel agents for cancer S.M. Sebti A.D. Hamilton Farnesyltransferase Inhibitors in Cancer Therapy 2001 Humana Press Tampa, FL 197 219
79. L. Sepp-Lorenzino Z. Ma E. Rands N.E. Kohl J.B. Gibbs A. Oliff N. Rosen A peptidomimetic inhibitor of famesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines Cancer Res. 55 1995 5302 5309
80. M. Sinensky Recent advances in the study of prenylated proteins Biochim. Biophys. Acta 1484 2000 93 106
81. C.L. Strickland W.T. Windsor R. Syto L. Wang R. Bond Z. Wu J. Schwartz H.V. Le L.S. Beese P.C. Weber Crystal structure of famesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue Biochemistry 37 1998 16601 16611
82. N. Suzuki K. Del Villar F. Tamanoi Farnesyltransferase inhibitors induce dramatic morphological changes of KNRK cells that are blocked by microtubule interfering agents Proc. Natl. Acad. Sci. USA 95 1998 10499 10504
83. W.R. Tschantz E.S. Furfine P.J. Casey Substrate binding is required for release of product from mammalian protein farnesyltransferase J. Biol. Chem. 272 1997 9989 9993
84. D.B. Whyte P. Kirschmeier T.N. Hockenberry I. Nunez-Oliva L. James J.J. Catino W.R. Bishop J.-K. Pai K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors J. Biol. Chem. 272 1997 14459 14464
85. W. Ying L. Sepp-Lorenzino K. Cai P. Aloise P.S. Coleman Photoaffinity-labeling peptide substrates for famesyl-protein transferase and the intersubunit location of the active site J. Biol. Chem. 269 1994 470 477
86. K. Yokoyama M.H. Gelb Protein geranylgeranyltransferase type I F. Famanoi D.S. Sigman 3rd. ed. The Enzymes Vol. 21 2000 Academic Press San Diego, CA 105 130
87. K. Yokoyama G.W. Goodwin F. Ghomashchi J.A. Glomset M.H. Gelb A protein geranylgeranyltransferase from bovine brain: Implications for protein prenylation specificity Proc. Natl. Acad. Sci. USA 88 1991 5302 5306
88. K. Yokoyama P. McGeady M.H. Gelb Mammalian protein geranylgeranyltransferase-I: Substrate specificity, kinetic mechanism, metal requirements, and affinity labeling Biochemistry 34 1995 1344 1354
89. K. Yokoyama K. Zimmerman J. Scholten M.H. Gelb Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein famesyltransferase and its consequences on the specificity of protein prenylation J. Biol. Chem. 272 1997 3944 3952
90. F.L. Zhang P.J. Casey Influence of metals on substrate binding and catalytic activity of mammalian protein geranylgeranyltransferase type-I Biochem. J 320 1996 925 932
91. F.L. Zhang P.J. Casey Protein prenylation: Molecular mechanisms and functional consequences Annu. Rev. Biochem. 65 1996 241 269
92. F.L. Zhang R.E. Diehl N.E. Kohl J.B. Gibbs B. Giros P.J. Casey C.A. Omer cDNA cloning and expression of rat and human protein geranylgeranyltransferase type I J. Biol. Chem. 269 1994 3175 3180
93. F.L. Zhang J.F. Moomaw P.J. Casey Properties and kinetic mechanism of recombinant mammalian protein geranylgeranyltransferase type I J. Biol. Chem. 269 1994 23465 23470
94. F.L. Zhang P. Kirschmeier D. Carr L. James R.W. Bond L. Wang R. Patton W.T. Windsor R. Syto R. Zhang W.R. Bishop Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I J. Biol. Chem. 272 1997 10232 10239